Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas

Title
Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas
Authors
Keywords
-
Journal
Journal of Thoracic Oncology
Volume 4, Issue 10, Pages 1270-1273
Publisher
Elsevier BV
Online
2009-09-19
DOI
10.1097/jto.0b013e3181b6be57

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started